| Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man E Charmandari, GP Chrousos, GI Lambrou, A Pavlaki, H Koide, SSM Ng, ... PLoS one 6 (9), e25612, 2011 | 120 | 2011 |
| Identification of common differentially expressed genes in urinary bladder cancer A Zaravinos, GI Lambrou, I Boulalas, D Delakas, DA Spandidos PLoS one 6 (4), e18135, 2011 | 117 | 2011 |
| Expression of miRNAs Involved in Angiogenesis, Tumor Cell Proliferation, Tumor Suppressor Inhibition, Epithelial-Mesenchymal Transition and Activation of Metastasis in Bladder … A Zaravinos, J Radojicic, GI Lambrou, D Volanis, D Delakas, ... The Journal of Urology 188 (2), 615-623, 2012 | 96 | 2012 |
| AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK N Nader, SSM Ng, GI Lambrou, P Pervanidou, Y Wang, GP Chrousos, ... Molecular Endocrinology 24 (9), 1748-1764, 2010 | 69 | 2010 |
| Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes E Ntoumou, M Tzetis, M Braoudaki, G Lambrou, M Poulou, K Malizos, ... Clinical Epigenetics 9 (1), 127, 2017 | 61 | 2017 |
| Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression GI Lambrou, S Vlahopoulos, C Papathanasiou, M Papanikolaou, ... Leukemia Research 33 (12), 1684-1695, 2009 | 54 | 2009 |
| Protein biomarkers distinguish between high-and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner M Braoudaki, GI Lambrou, K Vougas, K Karamolegou, GT Tsangaris, ... Journal of Hematology & Oncology 6 (1), 52, 2013 | 42 | 2013 |
| New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney A Zaravinos, GI Lambrou, N Mourmouras, P Katafygiotis, ... PLoS One 9 (3), e100063, 2014 | 41 | 2014 |
| Stress and inflammatory biomarkers and symptoms are associated with bioimpedance measures C Tsigos, C Stefanaki, GI Lambrou, D Boschiero, GP Chrousos European Journal of Clinical Investigation 45 (2), 126-134, 2015 | 40 | 2015 |
| Implication of RAF and RKIP genes in urinary bladder cancer A Zaravinos, M Chatziioannou, GI Lambrou, I Boulalas, D Delakas, ... Pathology & Oncology Research 17 (2), 181-190, 2011 | 40 | 2011 |
| Spotlight on differentially expressed genes in urinary bladder cancer A Zaravinos, GI Lambrou, D Volanis, D Delakas, DA Spandidos PLoS One 6 (4), e18255, 2011 | 39 | 2011 |
| MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact G Evangelatos, GE Fragoulis, V Koulouri, GI Lambrou Autoimmunity Reviews 18 (11), 102391, 2019 | 37 | 2019 |
| Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder. A Zaravinos, D Volanis, GI Lambrou, D Delakas, DA Spandidos Oncology Reports 28 (4), 1159-66, 2012 | 37 | 2012 |
| Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma A Zaravinos, P Kanellou, GΙ Lambrou, DA Spandidos Tumor Biology 35 (5), 4987-5005, 2014 | 36 | 2014 |
| Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible? JA Copland, M Sheffield-Moore, N Koldzic-Zivanovic, S Gentry, ... Bioessays 31 (6), 629-641, 2009 | 34 | 2009 |
| Dysregulated placental microRNAs in early and late onset preeclampsia A Lykoudi, A Kolialexi, GI Lambrou, M Braoudaki, C Siristatidis, ... Placenta 61, 24-32, 2018 | 32 | 2018 |
| Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms M Braoudaki, GI Lambrou, K Giannikou, V Milionis, K Stefanaki, DK Birks, ... Journal of Hematology & Oncology 7 (1), 96, 2014 | 27 | 2014 |
| miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas M Braoudaki, GI Lambrou, K Giannikou, SA Papadodima, A Lykoudi, ... Tumor Biology 37 (7), 9887-9897, 2016 | 22 | 2016 |
| Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: Multiple, diverse signals converging on a few key downstream regulators GI Lambrou, L Papadimitriou, GP Chrousos, SA Vlahopoulos Molecular and Cellular Endocrinology 351 (2), 142-51, 2012 | 22 | 2012 |
| Antioxidant properties of Crocus sativus L. and its constituents and relevance to neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease K Hatziagapiou, E Kakouri, GI Lambrou, K Bethanis, PA Tarantilis Current Neuropharmacology 17 (4), 377-402, 2019 | 21 | 2019 |
